Jiangsu Alphamab Biopharmaceuticals Co., Ltd

This is the first study in humans to test a new injectable cancer drug called JSKN016HC. The main goals are to find a safe dose and see how the body handles the drug. It will involve 42 adults with advanced solid tumors that have stopped responding to standard treatments.

This study is testing a new two-drug combination (JSKN016 given by IV and D-0502 taken as a pill) for people with advanced breast cancer that is hormone-sensitive and HER2-negative, and that has worsened after standard hormone-based therapy. The main goals are to find a safe dose…

This is the first study in people to test a new cancer drug called JSKN027. Researchers will give the drug to patients with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find a safe dose and see if the drug causes tumors to shrin…

This study is testing a new drug called JSKN033 for adults with advanced non-small cell lung cancer (NSCLC) that cannot be cured by surgery or radiation. The main goals are to see how safe the drug is and if it can shrink or control the cancer. The study will also measure how the…